קופקסון - COPAXONE

בסל התרופות: כן

מספר רישום: 128-06-30681-00

For reducing the frequency of relapses in pateints with relapsing-remitting multiple sclerosis. Copaxone is indicated for the treatment of patients who have experienced a well defined first clinical episode and are determined to be at high risk of developing clinically definite multiple sclerosis (CDMS). These patients should have MRI findings which are compatible with the diagnosis of multiple sclerosis.

צורת מתן: הזרקה, תת עורי

צורת מינון: תמיסה להזרקה